Followers | 25 |
Posts | 1899 |
Boards Moderated | 0 |
Alias Born | 06/15/2007 |
Tuesday, April 21, 2020 7:58:47 AM
(“Theralase” or the “Company”)
(TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and
development of light activated Photo Dynamic Compounds (“PDC”) and associated drug
formulations has released the Company Quarterly Newsletter.
The Newsletter provides updates on the previous quarter and progress on the Phase II Non-Muscle
Invasive Bladder Cancer (“NMIBC”) Clinical Study. The Newsletter can be found on the Company’s
website www.theralase.com/invest/.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM